rapid enzyme-linked immunosorbent assay c. diff quick check complete kit (TechLab Inc)
90
Structured Review
TechLab Inc
rapid enzyme-linked immunosorbent assay c. diff quick check complete kit
Rapid Enzyme Linked Immunosorbent Assay C. Diff Quick Check Complete Kit, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rapid+enzyme-linked+immunosorbent+assay+c%2E+diff+quick+check+complete+kit/c++diff+quick+check+complete+enzyme+immunoassay/pm38754772-86-19-32
Average 90 stars, based on 1 article reviews
Rapid Enzyme Linked Immunosorbent Assay C. Diff Quick Check Complete Kit, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rapid+enzyme-linked+immunosorbent+assay+c%2E+diff+quick+check+complete+kit/c++diff+quick+check+complete+enzyme+immunoassay/pm38754772-86-19-32
Average 90 stars, based on 1 article reviews
rapid enzyme-linked immunosorbent assay c. diff quick check complete kit - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Clostridioides difficile infection in patients with and without COVID-19 during the pandemic: a retrospective cohort study from a tertiary referral hospital. Article Snippet: 31 Objectives: This study aims to detect the prevalence and specific characteristics of 32 Clostridioides difficile infection (CDI) during the COVID-19 pandemic.. 33 Methods: In this retrospective observational study, conducted in a tertiary hospital in 34 Greece between May 2021 and October 2022, patients with CDI from COVID-19 and Internal 35 Medicine wards were enrolled and compared based on epidemiological and disease36 associated data.. 37 Results: In total, 4322 patients were admitted, and 435 samples for CDI were analyzed, with 38 104/435 (23.9%) sample positivity and 2.4% prevalence. Diff-Quik:Article Title: Clostridioides difficile infection in patients with and without COVID-19 during the pandemic: a retrospective cohort study from a tertiary referral hospital. Article Snippet: 31 Objectives: This study aims to detect the prevalence and specific characteristics of 32 Clostridioides difficile infection (CDI) during the COVID-19 pandemic.. 33 Methods: In this retrospective observational study, conducted in a tertiary hospital in 34 Greece between May 2021 and October 2022, patients with CDI from COVID-19 and Internal 35 Medicine wards were enrolled and compared based on epidemiological and disease36 associated data.. 37 Results: In total, 4322 patients were admitted, and 435 samples for CDI were analyzed, with 38 104/435 (23.9%) sample positivity and 2.4% prevalence. |